How anxiety affects Alzheimer's disease differently in men and women

The sex specific impact of anxiety on Alzheimer's disease progression

NIH-funded research Rosalind Franklin Univ of Medicine & Sci · NIH-10806170

This study is looking at how anxiety might affect the progression of Alzheimer's disease, especially in women, by examining the brains of male and female mice to understand the connection between anxiety and memory loss.

Quick facts

Grant typeNIH-funded research
Study typeNIH-funded research
Funding institutionRosalind Franklin Univ of Medicine & Sci NIH-funded
Lab location1 site (North Chicago, United States)
Project IDNIH-10806170 on NIH RePORTER

What this research studies

This research investigates the relationship between anxiety and the progression of Alzheimer's disease (AD), focusing on how this relationship differs between sexes. By studying both male and female mice, the research aims to uncover the neural mechanisms linking anxiety to memory loss in AD. The approach includes advanced techniques such as optogenetics and in vivo calcium imaging to observe brain activity and behavior. The findings could lead to new insights into how anxiety may predict AD progression, particularly in women, who are disproportionately affected by the disease.

Who could benefit from this research

Good fit: Ideal candidates for this research are individuals with a diagnosis of Alzheimer's disease, particularly those experiencing anxiety symptoms.

Not a fit: Patients without Alzheimer's disease or those not experiencing anxiety may not benefit from this research.

Why it matters

Potential benefit: If successful, this research could lead to targeted therapies that address anxiety in Alzheimer's patients, potentially slowing disease progression.

How similar studies have performed: While the specific approach of this research is novel, previous studies have indicated that addressing neuropsychiatric symptoms like anxiety can impact the progression of neurodegenerative diseases.

Where this research is happening

North Chicago, United States

Researchers

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Conditions Alzheimer disease dementiaAlzheimer syndromeAlzheimer's Disease
Last reviewed 2026-06-13 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.